Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.135 USD | +13.36% | -54.00% | -59.88% |
05-08 | Top Midday Decliners | MT |
05-08 | UBS Adjusts Price Target on Treace Medical Concepts to $16 From $17, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-59.88% | 281M | |
+73.63% | 12.4B | |
-17.14% | 7.94B | |
-0.92% | 6.17B | |
+16.74% | 5.55B | |
-3.21% | 5.35B | |
+46.20% | 5.03B | |
-17.73% | 4.07B | |
-30.31% | 2.65B | |
-0.74% | 1.99B |
- Stock Market
- Equities
- TMCI Stock
- News Treace Medical Concepts, Inc.
- Morgan Stanley Adjusts Price Target on Treace Medical Concepts to $30 From $28, Maintains Overweight Rating